埃森哲：2026年从实验室到生产线：生物制药行业全链条智能化重构研究报告（英文版）

Manufacturing is now on the critical path to delivering essential medicines to patients, a pivotal moment that demands tighter integration from lab to line to ensure speed, reliability, and quality. Complex biologics pipelines, AI-accelerated R&D and mounting geopolitical and economic pressures have catapulted manufacturing to a top priority, and with good reason— 64% of drug-launch delays in 2024 stemmed from chemistry, manufacturing and control issues